Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells
Tamoxifen is the first line drug used in the treatment of estrogen receptor-positive (ER+) breast cancer. The development of multidrug resistance (MDR) to tamoxifen remains a major challenge in the treatment of cancer. One of the mechanisms related to MDR is decrease of drug influx via overexpressio...
Main Authors: | Desak Gede Budi Krisnamurti, Melva Louisa, Erlia Anggraeni, Septelia Inawati Wanandi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Advances in Pharmacological Sciences |
Online Access: | http://dx.doi.org/10.1155/2016/6702424 |
Similar Items
-
Kurkumin Meningkatkan Sensitivitas Sel Kanker Payudara terhadap Tamoksifen Melalui Penghambatan Ekspresi P-glikoprotein dan Breast Cancer Resistance Protein
by: Erlia Anggrainy Sianipar, et al.
Published: (2018-04-01) -
Differential expression of several drug transporter genes in HepG2 and Huh-7 cell lines
by: Melva Louisa, et al.
Published: (2016-01-01) -
Effect of Allicin on Tamoxifen-sensitive MCF-7 Breast Cancer Cells
by: P Rahimi-Moghaddam, et al.
Published: (2015-05-01) -
Simvastatin Evokes An Unpredicted Antagonism For Tamoxifen In MCF-7 Breast Cancer Cells
by: Ibrahim AB, et al.
Published: (2019-11-01) -
The Effect of Alpha Mangostin on Epithelial-Mesenchymal Transition on Human Hepatocellular Carcinoma HepG2 Cells Surviving Sorafenib via TGF-β/Smad Pathways
by: Syarinta Adenina, et al.
Published: (2020-08-01)